The metabolite lactic acid produced by bifidobacteria alleviates inflammation and lipid metabolism disorders in NAFLD mice induced by a HFD through the inhibition of the NLRP3 inflammasome activation. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.